Wilfred Ngwa
Affiliations: | Johns Hopkins University, Baltimore, MD |
Google:
"Wilfred Ngwa"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Moreau M, Keno LS, China D, et al. (2024) Investigating the Use of a Liquid Immunogenic Fiducial Eluter Biomaterial in Cervical Cancer Treatment. Cancers. 16 |
| Joseph A, Akinsete AM, Lasebikan NN, et al. (2024) The Landscape of Pediatric Radiation Oncology in Nigeria. Jco Global Oncology. 10: e2300219 |
| Moreau M, Acter S, Ngema LM, et al. (2023) Pre-Clinical Investigations of the Pharmacodynamics of Immunogenic Smart Radiotherapy Biomaterials (iSRB). Pharmaceutics. 15 |
| Ainsworth V, Moreau M, Guthier R, et al. (2023) Smart Radiotherapy Biomaterials for Image-Guided In Situ Cancer Vaccination. Nanomaterials (Basel, Switzerland). 13 |
| Acter S, Moreau M, Ivkov R, et al. (2023) Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment. Nanomaterials (Basel, Switzerland). 13 |
| Alfonzetti T, Moreau M, Yasmin-Karim S, et al. (2023) Phytoradiotherapy to enhance cancer treatment outcomes with cannabidiol, bitter melon juice, and plant hemoglobin. Frontiers in Oncology. 12: 1085686 |
| Petrovic LZ, Oumano M, Hanlon J, et al. (2022) Image-Based Quantification of Gold Nanoparticle Uptake and Localization in 3D Tumor Models to Inform Radiosensitization Schedule. Pharmaceutics. 14 |
| Swanson W, Samba RN, Lavelle M, et al. (2021) Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in Africa. Frontiers in Oncology. 11: 725103 |
| Swanson W, Kamwa F, Samba R, et al. (2020) Hypofractionated Radiotherapy in African Cancer Centers. Frontiers in Oncology. 10: 618641 |
| Alfonzetti T, Yasmin-Karim S, Ngwa W, et al. (2020) Phytoradiotherapy: An Integrative Approach to Cancer Treatment by Combining Radiotherapy With Phytomedicines. Frontiers in Oncology. 10: 624663 |